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ABSTRACT Synchronized C3H/IOTI/2 clone 8 cells were
treated in vitro with a nontoxic dose of N-methyl-N-nitrosourea
during their S phase. Chromatographic isolation of the deoxyri-
bonucleotide DNA precursor pool and measurement of the pre-
cursor content per cell showed that a nucleic acid residue in the
precursor pool is 190-13,000 times more susceptible to methyla-
tion- than a residue in the DNA duplex, depending on the site of
methylation. This conclusion comes from measurements indicat-
ing that, for example, the N-i position of adenine in dATP is 6.3
times more methylated than the same position in the DNA, even
though the adenine content of the pool is only a fraction (0.0005)
of the adenine content of the DNA helix. The comparative sus-
ceptibility between pool and DNA was found to vary with the site
of methylation in the order the N-i position of adenine > phos-
phate > the N-3 position of adenine > the 06 position of guanine
> the N-7 position of guanine. The significance of these results
for chemical mutagenesis and carcinogenesis is discussed.
We recently proposed, from chemical considerations, that the
pool of DNA precursor deoxyribonucleotides should be a sig-
nificant target in vivo for chemical mutagens (1). Such chemical
modification of the precursor pool could have significant bio-
logical consequences. For example, modified precursors might
inhibit nucleotide binding enzymes and perturb DNA repli-
cation. Indeed, modification of precursors together with rapid
turnover of the nucleotide pool (for discussion, see ref. 2) may
offer a direct explanation for the S-phase dependence of alkyl-
ation-induced mutation (3) and neoplastic transformation (4, 5)
of cells in culture and the chromosome replication point spec-
ificity of alkylating agents in bacteria (6, 7). In support of our
proposal, dATP was shown to be a good target in vitro for N-
methyl-N-nitrosourea (MNU), a potent methylating agent, mu-
tagen, and carcinogen (1). Moreover, methylated nucleotide
products from this reaction were found to incorporate into DNA
during replication by bacteriophage T4 DNA polymerase in
vitro (1). For these in vitro results to be applicable in vivo, how-
ever, the DNA precursor pool must be shown to be a significant
target for MNU.
In this paper, we report that the DNA precursor pool in
mouse embryo fibroblast C3H/1OT'/2 clone 8 cells (lOT'/2 cells)
(8) is modified to a greater extent per cell than is the DNA.
Furthermore, determination of the cellular content of deoxy-
ribonucleotide residues in the precursor pool enables us to con-
clude that the purine nucleotide residues in the pool are
190-13,000 times more susceptible to modification by MNU
than the same residues in the DNA helix, depending on the site
being modified. The order of susceptibility was found to be the
N-1 position of adenine > phosphate > the N-3 position of ad-
enine > the 06 position of guanine > the N-7 position of
guanine.
MATERIALS AND METHODS
Deoxyribonucleotides, Deoxyribonucleosides, and Meth-
ylated Purine Standards. Purity of dNTPs and deoxyribonu-
cleosides (Sigma) was determined by chromatography on po-
lyethyleneimine-cellulose and ion exchange HPLC. Purity of
1-methyladenine (IMeAde), 3-methyladenine (3MeAde), 7-
methyladenine (7MeAde), 1-methylguanine (lMeGua), 3-
methylguanine (3MeGua), and 7-methylguanine (7MeGua)
(Vega Biochemicals) and N2-methylguanine (N2MeGua) and N2-
dimethylguanine (N2Me2Gua), prepared from N2-methylgua-
nosine and N2-dimethylguanosine (P.-L. Biochemicals) by acid
hydrolysis, was determined by reverse-phase C18 HPLC and
verified by their spectral characteristics (9, 10). 06-Methylgua-
nine (O6MeGua) was synthesized from 2-amino-6-chloropurine
(Aldrich) according to published procedures (11), purified by
reverse-phase C18 HPLC, and identified by its spectral char-
acteristics (11).
Carcinogen Treatment and Fractionation of S-Phase 10T'A
Cells. lOT12 cells growing in 100-mm tissue culture dishes were
synchronized with respect to growth cycle by postconfluence
inhibition ofcell division (8). On entering S phase, cells on three
or four dishes were washed twice with Tris-buffered saline (pH
7.6) and then treated for 30 min at 37°C with 2 ml of 0.04 mM
[3H]MNU (1-1.6 Ci/mmol; 1 Ci = 3.7 x 1010 becquerels; New
England Nuclear) in the same saline. This dose kills <20% of
these cells (unpublished results). After treatment with MNU,
the cells were washed twice with Tris-buffered saline, and lysed
by addition to each dish of 2 ml of 100 mM NaCl/10 mM
EDTA/0.5% Triton X-100, pH 7 to 8. Lysis occurred within 2
min at room temperature. The lysis solution was carefully re-
moved with a Pasteur pipette, leaving intact nuclei adhering
to the dish. The nuclei were then washed twice with 100 mM
NaCl/10mM EDTA, pH 7 to 8. DNA was extracted for specific
activity determination by lysing the nuclei with Sarkosyl/pro-
teinase K (Worthington) and then banding the DNA in the ly-
sates in a CsCl gradient. The DNA band was isolated, dialyzed,
treated with RNase A, and then rebanded in CsCl. The amount
ofDNA isolated per nucleus was equivalent to that consistently
isolated per intact cell, showing that nuclei were not lost during
the procedure.
Isolation of the Deoxyribonucleotide Precursor Pool from
Carcinogen-Treated Cells. To isolate deoxyribonucleotides,
the Triton lysate (at 4°C) was filtered through a 0.45-,um Mil-
Abbreviations: MNU, N-methyl-N-nitrosourea; lOThA, C3H/IOT'/2
clone 8; lMeAde, 3MeAde, and 7MeAde, 1-, 3-, and 7-methyladenine,
respectively; lMeGua, 3MeGua, 7MeGua, O6MeGua, and N9MeGua,
1-, 3-, 7-, o6-, and N2-methylguanine, respectively; N2Me2Gua, N2-
dimethylguanine.
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lipore filter and then extracted three times with phenol to re-
move protein and lipid. The aqueous phase was washed twice
with ether to remove the remaining [3H]MNU, lipid, and
phenol and then adjusted to 0.5 M ammonium acetate/20 mM
MgCl2, pH 8.5, and passed through a 0.7 X 15.0 cm column
of phenylboronic acid/polyacrylamide (Bio-Rad Affi-Gel 601)
at a flow rate of 1 ml/min. These conditions completely re-
tained ribose-containing molecules on the Affi-Gel while not
retaining deoxyribose molecules (12), which eluted in the void
volume. The column was washed with 3 to 4 vol of buffer and
the unbound sample was pooled and diluted with water to 0.1
M ammonium acetate (pH 8.0). This was passed through a 0.7
X 30 cm column of QAE-Sephadex A-25 (Pharmacia). At pH
8.0 and 0.1 M ionic strength, deoxyribonucleotides are nega-
tively charged and bind to this anion exchanger. After passing
the sample through and washing the column with 100 ml of 0.1
M ammonium acetate to remove weakly charged molecules,
bound deoxyribonucleotides were eluted in 50 ml of 1 M am-
monium acetate (pH 8.5).
HPLC Analysis of Methylated Purines. The 50-ml sample
was lyophilized to dryness, suspended in 6 M HC1 (final pH,
1.0), and incubated at 37C for 20 hr to yield free 1MeAde,
3MeAde, 7MeGua, and O6MeGuawithno loss of methyl group
(10). One hundred microliters of the hydrolyzed sample was
chromatographed on an MCH-10 octyldecylsilane reverse-
phase high-pressure-column (Varian). Elution was at a flow rate
of 0.7 ml/min with, for the first 50 min, a mobile phase of 95%
0.01 M NaPOJ5% methanol, pH 4.0, for the next 15 min, a
0-35% methanol/water gradient, and, for the last 10 min, 35%
methanol. One-minute fractions were collected for monitoring
of radioactivity by liquid scintillation counting.
Quantitation of the Concentration of Cellular Deoxyribo-
nucleotides in the DNA and in the Precursor Pool. The nu-
cleotide content of the DNA per 106 cells was determined from
the UV absorbance of the extracted DNA preparation assuming
an extinction coefficient of 6.5 X 103. Intracellular dNTP pools
were measured enzymatically as described by Skoog (13). The
dependence of "elongation" of DNase-activated calf thymus
DNA by Escherichia coli DNA polymerase I (Boehringer-
Mannheim) on the concentration of dNTP was measured by
using one radioactive dNTP at several rate-limiting concentra-
tions while keeping the three remaining dNTPs present in ex-
cess. These measurements were used to determine the dNTP
concentrations in perchloric acid-soluble cellular extracts that
served as the rate-limiting substituent in the same reaction.
RESULTS
Distribution of Radioactivity During Isolation of Deoxyri-
bonucleotides from Cells Treated with [3H]MNU. The pro-
cedure for isolating deoxyribonucleotide precursors described
in Materials and Methods is summarized in Fig. 1. To deter-
mine whether the isolate of methyl-adducted deoxyribonucleo-
tide precursors was free ofother possible methylated molecules,
radiolabelled compounds representative of those molecules
likely to contaminate our final isolate were carried through all
or part of this procedure. These included ['4C]methyl-labeled
proteins (bovine serum albumin, carbonic anhydrase, lyso-
zyme, myosin, ovalbumin, and phosphorylase-b), [3H]leucine,
nonradiolabeled glutamic acid (a negatively charged amino acid
at neutral pH), [3H]ATP, and [3H]TTP. The results indicated
that 99.5% ofthe protein was removed during phenol extraction
(also expected to remove lipids during the ether wash) at step
4 (Fig. 1). Of the 0.5% left, 0.46% bound to the anion exchange
column at step 6. Only 0.2% of the initial protein eluted from
the column at the pH and ionic strength used to elute deoxy-
ribonucleotides at step 7. Thus, at most, 0.2% of the radioac-
tivity removed by the phenol step will contaminate the radio-
activity eluted as deoxyribonucleotides. [3H]Leucine was tested
for binding to this column and no detectable radioactivity was
found. Also, no glutamic acid was detected by UV absorbance.
[3H]ATP was completely retained by the phenylboronic acid
affinity column (at step 5 of the procedure). This matrix has an
exclusion limit of 6,000 daltons and a high capacity for binding
compounds that have coplanar cis-diol groups such as ribonu-
cleotides and -sides, sugars, catecholamines, and coenzymes.
[3H]TTP was used to test for deoxyribonucleotide loss at each
step. Approximately 15% loss occurred during phenol extrac-
tion. This figure varied with the experiment but never exceeded
30%. No [3H]TTP was lost during phenylboronic acid affinity
chromatography, and recovery by the anion exchange steps (6
and 7) was always >95%. The final isolate ofmethylated deoxy-
ribonucleotide, therefore, is probably contaminated only by the
amounts of protein discussed below. Its measured concentra-
tion, however, may be underestimated due to losses during the
procedure.
To determine the effect ofMNU on the precursor pool, LOT'/2
cells were treated with [3H]MNU as described and then carried
through the deoxyribonucleotide isolation procedure. Total ra-
dioactivity remaining in the sample after each step is shown in
Table 1. The largest amount of radioactivity was removed by
phenol extraction. This is consistent with extensive protein
methylation by MNU. Methyl groups associated with deoxy-
ribonucleotide pools represent %2% ofthe methyl groups pres-
ent in the total cell lysate. Although small, this amount of meth-
ylation is greater than that found in the cell DNA. The 0.2%
of radiolabel associated with protein that may contaminate the
radiolabel associated with presumed deoxyribonucleotides
amounted to <6.3%, 6.6%, and 67.5% of the radiolabel eluted
from QAE-Sephadex (step 7) in experiments 1, 2, and 3, re-
spectively. Thus, contamination cannot account for the elution
products in experiments 1 and 2.
Susceptibility of Pool and DNA Deoxyribonucleotide to
Methylation by MNU. The radioactivity eluted from QAE-
Sephadex (step 7) and the radioactivity found in DNA were con-
verted to picomoles of methyl group by using the specific ac-
tivity of the [3H]MNU. More variability occurs in the data for
pool methylation shown in Table 1 than in those for DNA meth-
ylation. This is probably due to the smaller amount of material
and greater number of manipulations involved in purification
of precursors than in purification of DNA. Despite such ex-
perimental error, the results of three independent determi-
nations indicate 1.2- to 7.6-fold greater methylation of pool
deoxyribonucleotide residues than of DNA residues.
To compare methylation per nucleotide residue in the pool
with that in the DNA it is necessary to know the nucleotide
content per cell in both. The results of three independent mea-
surements of pool content in S-phase LOT'A cells are given in
Table 2. Each dNTP was separately measured for a total dNTP
content of 76 pmol per 106 cells. The relative sizes of the in-
dividual pools agree with measurements from other mouse em-
bryo cell lines (for review, see ref. 2), in which dCTP is generally
the largest pool and dGTP is the smallest. We did not resolve
dUTP, the spontaneous deamination product of dCTP, from
dTTP in our measurements. Thus, dTTP may be slightly over-
estimated and dCTP may be slightly underestimated. How-
ever, this does not affect the final determination of total deoxy-
ribonucleotide content in the DNA precursor pool.
The DNA was shown, from UV absorbance measurements,
to contain 85,900 pmol of nucleotide per 106 cells.
HPLC Analysis of Methylated DNA Precursors. To study
the nature of the products formed by interaction of [3H]MNU
Proc. Nad Acad. Sci. USA 79 (1982)



















QAE Sephadex anion 0 0 Phenyl-boronic
exchange column acid column binds
binds deoxynucleotides m cis-diols
FIG. 1. Purification of cellular deoxyribonucleotide precursors. A, Protein and lipid; o, molecule with cis-diol groups; m, deoxynucleotide; o,
deoxynucleosides and amino acids.
with deoxyribonucleotide and to further purify the pool resi-
dues, the eluate from QAE-Sephadex chromatography (step 7)
in experiment 3 was acid hydrolyzed to release purines and ana-
lyzed by reverse-phase HPLC. The elution pattern when the
radioactive sample was cochromatographed with methylated
purine standards is shown in Fig. 2. The majority ofradioactivity
(retained < 10 min) contained unhydrolyzed purine and pyrimi-
dine nucleotides, methylated sugar phosphate moieties, and
free methylated phosphate. Later eluting peaks cochromato-
graphed with 1MeAde, 3MeAde, 7MeGua, and O6MeGua stan-
dards; picomoles of methyl group per 106 cells chromatograph-
ing as each ofthese species were 0.069, 0.028, 0.069, and 0.013,
respectively. No products chromatographed with 3MeGua,
lMeGua, 7MeAde, N2MeGua, or N2Me2Gua standards (not
shown). Our ability to resolve the elution products from the
anion exchange column into peaks that cochromatograph with
authentic methylated purines, and the fact that these products
are those predicted to occur in significant yield, confirm our
ability to isolate the deoxyribonucleotide pools.
A major site ofreaction ofMNU with DNA precursors should
be the phosphate groups because oftheir electronegativity. The
amount of phosphate methylation by MNU is given in Table 3.
The unidentified category of methylated products contains
methylated pyrimidines and total phosphate modification.
Since methylation of pyrimidine bases represents a small frac-
tion of total modification, we assume that phosphate modifi-
cation is 0.644 of total modified. This represents 75% of total
pool modification. Such a large amount was expected because
the level of phosphate modification of DNA in vitro, in which
there is only one phosphate moiety per residue, is =20%
(14-17).
DISCUSSION
Our experiments show that MNU significantly modifies the
DNA precursor pools of S-phase 10T'/2 cells in culture. Com-
parison of amounts of specific methyl adducts in the pool with
those in the DNA shows 1.2-7.6 times more modification of the
pools. This result gains added significance from measurements
ofamounts ofdeoxyribonucleotides per S-phase cell in the form
of precursors and in the form of DNA residues. These mea-
surements show (on average) 1,100-fold more residues in the
DNA than in the pools. Thus, a residue in the precursor pool
Table 1. Distribution of radioactivity during isolation of dNTP from [3H]MNU-treated lOT'/2 cells
Radioactivity, cpm x 10-3/106 cells remaining after step
Precursor pool
Enucleated Phenol QAE-Sephadex elution
cell lysate extraction Affi-Gel 0.1 M NH4OAc 1.0 M NH4OAc
Exp. (step 3) (step 4) (step 5) (step 6) (step 7) DNA Pool/DNA
1 386 149 40 25 7.6 (4.7) 1.0 (0.63) 7.6
2 298 78 28 20 6.7 (4.2) 1.4 (0.88) 4.8
3 580 86 29 25 1.5 (0.91) 1.2 (0.75) 1.2
All data were normalized for differences in cell number between experiments. Results in parentheses represent pmol of methyl group per 106 cells
and were calculated by dividing cpm x 10-3 by specific activity of the [3H]MNU.
Biochemistry: Topal and Baker
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Table 2. Deoxyribonucleotide in pools and in DNA
pmol per 106 cells
dATP 12.3 ± 4.9
dCTP 36.0 ± 0
dGTP 12.0 ± 1.2
dTTP and dUTP 15.8 ± 1.6
Total dNTP 76
DNA 85,900
is, on average, 1,300-8,400 times more susceptible to meth-
ylation than a residue in the DNA of these cells.
Since we could not be sure that the isolated pools were free
of contaminating methylated cellular molecules, we made the
more stringent comparison by reverse-phase HPLC of meth-
ylation of pool and DNA nucleotides at specific sites. Amounts
of the four major methyl purines formed during reaction of
MNU with the precursor pool are compared with the amounts
formed in the DNA in Table 3. Also shown are unidentified
products, which include methylated pyrimidines and all phos-
phate methylations. The results indicate that susceptibility to
MNU methylation ofa residue in the DNA precursor pool com-
pared with that in the DNA varies with the site of modification.
This is to be expected from DNA structural interactions. For
example, the N-1 position of adenine is involved in hydrogen
bonding and is located, out ofreach of solvent, in the interstices
of the helical duplex. On the other hand, this same position in
the nucleotide precursor is readily available for modification.
This difference is manifested as a 13,000-fold greater suscep-
tibility of the N-1 position of dATP to methylation by MNU
compared with the susceptibility of this same position in the
adenosine residues in DNA. The N-7 position ofguanine, mean-
while, is more available in the DNA than is the N-1 position of
adenine because of its location in the major groove of the helix.
This is reflected in a more moderate difference in susceptibility
between precursor and DNA guanosine residues at this posi-
tion. All of the sites show greater susceptibility in the triphos-
phate precursor compared with the DNA: greater amounts of
methyl phosphate, 3MeAde, and O6MeGuawere also found per
residue in the precursor pool than in the DNA. The larger dif-
ferences are manifested by those sites least accessible in the
DNA helix.
The site exhibiting the largest amount of methylation (75%
of total methylation), and one of the largest differences in sus-
70
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FIG. 2. HPLC separation of methylated purines resultingfrom the
reaction of MNU with the DNA precursor pool of lOT'/2 cells. Acid-
hydrolyzed precursors were chromatographed on a C18 reverse-phase
column at a flow rate of 0.7 ml/min.
ceptibility, was found to be methylation of the phosphate
moiety. This is not surprising since MNU is believed to act
through a strongly electrophilic intermediate (for review, see
ref. 18) that should be influenced by the highly electronegative
phosphate group (19). The large difference in susceptibility of
the phosphates ofprecursor and DNA (Table 3) is probably due
to protection ofDNA by binding of positively charged proteins
such as histones. The effect of dNTP precursors with methyl-
ated phosphates on DNA replication is unknown.
The great susceptibility of the dNTP precursors to methyl-
ation suggests that, during treatment of an S-phase cell with a
methylating agent such as MNU, there will be a significant con-
centration of methylated precursors competing with normal
precursors for incorporation into the DNA daughter strand.
Evidence that such precursors are indeed incorporated comes
from our results that show the ability ofproducts ofthe reaction
ofMNU with dATP to be incorporated by phage T4 DNA poly-
merase during replication of 4X174 DNA in vitro (1). This sug-
gests that the large quantitative differences between precursor
and DNA methylation found may actually be underestimates.
Table 3. Site susceptibility of nucleotide residues in precursor pool and DNA to methylation by
MNU
Methyl groups, pmol per 106 cells Relative pool
Modification Pools DNA* Pool/DNA susceptibilityt
IMeAde 0.069 0.011 (0.005-0.017) 6.3 13,000
3MeAde 0.028 0.056 (0.039-0.071) 0.50 1,000
7MeGua 0.069 0.502 (0.457-0.585) 0.13 190
O6MeGua 0.013 0.047 (0.026-0.058) 0.28 400
Unidentifiedt 0.644 0.146 (0.112-0.184) 4.4 5,000
* Data for extent of methylation of DNA at these sites were obtained from refs. 14-17 and are mean
(range). The mean values were used to determine thepool/DNA ratio and the relative pool susceptibility.
The reported values agree well with each other and with our preliminary measurements.
t Determined from the pool/DNA methylation ratio (this table), for a particular site, normalized for the
large difference (Table 2) in nucleotide content between pool and DNA. Normalization was achieved by
multiplying the pool/DNA methylation ratio by the appropriate ratio of DNA nucleotide content/pool
nucleotide content per cell. The latter ratios were determined to be 1,432 for guanine, 2,095 for adenine,
and 1,130 for total nucleotide assuming a DNA G/C content of 40% for lOT'/2 cells and using the mea-
sured nucleotide content per cell values of Table 2.
t Determined to be mainly phosphate methylation by treatment of the deoxynucleotides with acid to hy-
drolyze purines and with alkaline phosphatase to remove unmethylated phosphates. With both treat-
ments, the majority of radioactivity cochromatographed on reverse-phase HPLC with a propyl phosphate
standard provided by Richard Wolfendon but not with standards indicating base methylation.
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Some methyl adducts we detected in the DNA may have come
from incorporation of modified precursors during the 30 min-
utes ofreplication taking place while the cells were treated with
MNU. Indeed, detailed characterization of the DNA isolated
from these cells indicates greater than five-fold preferential
methylation (compared with that expected from random meth-
ylation) of the DNA replicated during the time of treatment of
the cells with MNU (unpublished results). Moreover, we expect
such incorporation to contribute to mutation and neoplastic
transformation. Modified residues, now in the template strand,
may misdirect incorporation of precursors during the next
round of DNA replication in the cell. For example, deoxy-1-
methyladenosine triphosphate, which we found to be one ofthe
major modified purine products produced during incubation of
lOT1/2 cells with MNU, has been shown to cause incorporation
errors during "transcription" of synthetic ribopolymers con-
taining methylated bases by DNA-dependent RNA polymerase
(20). Methylated template residues may also be subject to high
rates ofdepurination, which has recently been suggested, under
certain conditions, to be mutagenic (21). Moreover, some DNA
modifications may induce error-prone repair systems in the cell
(22). Finally, it is interesting to note that deoxy-N6-methylad-
enosine triphosphate is expected as a minor product of pool
methylation. Incorporation ofthis modified precursor into DNA
could have significant biological consequences since deoxy-N6-
methyladenosine in helical DNA is involved in the restriction-
modification system in bacteria (for review, see ref. 23) and
possibly in control of gene expression and differentiation in eu-
karyotic cells (24, 25).
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